{"disease":{"id":"exsanguinating-hemorrhage","name":"exsanguinating hemorrhage"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02880163","title":"REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam","phase":"NA","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Arsenal Medical, Inc.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}